Neuropsychological and Neuroanatomical Studies of Young Children With and Without Type 1 Diabetes Mellitus
- Conditions
- Type 1 Diabetes Mellitus
- Registration Number
- NCT00449891
- Lead Sponsor
- Stanford University
- Brief Summary
This study is being conducted to see if Type 1 diabetes mellitus has any affect on learning, behavior and development in young children and whether there are associated changes on their MRI scan.
- Detailed Description
In this pilot study approximately 10-20 children between the ages of 3 to 10 years with Type 1 diabetes mellitus will have neuropsychological testing and a nonsedated MRI scan of the head performed every three years for three years. We will compare this to a control group of 10 children between the ages of 3 adn 10 years without Type 1 diabetes mellitus. The control subjects will neuropsychological testing and a nonsedated MRI scan of the head once. The children with Type 1 diabetes mellitus will not have any changes made to their current diabetes regimen.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria for study subjects:
- To be between ages 3 to 10 years
- Have been diagnosed with type 1 diabetes for at least 6 months; and
- Do not have plans to move out of the area within the next 36 months.
Inclusion Criteria for control subjects:
- To be between ages 3 to 10 years
- No history of head trauma with any loss of consciousness,
- Cystic fibrosis,
- Prematurity (born less than 30 weeks of gestation),
- Significant developmental delay (lack of single word speech or ability to walk independently by 18 months of age),
- Neurologic disease independent of diabetes (eg seizure disorder); or
- Medical contraindication to MRI procedure (eg metal appliances such as braces).
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
Trial Locations
- Locations (1)
Stanford University
🇺🇸Stanford, California, United States
Stanford University🇺🇸Stanford, California, United States